RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Bulenox vs FundedFirm

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

BLNX

Bulenox

EST. 2022

FNFM

FundedFirm

BULENOX

METRIC

FUNDEDFIRM

71/100BETTER

TRUST SCORE

—0/100

0/5TIE

RATING

TIE0/5

80%—

PROFIT SPLIT

BETTER100%

$150,000BETTER

MAX FUNDING

—$100,000

$99BETTER

MIN COST

—$549

14d—

PAYOUT DAYS

BETTER1d

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

BULENOX DETAILS

STEPS: 1-phase
DRAWDOWN: Fixed
MARKETS: Futures
PLATFORMS: NinjaTrader, Rithmic, Tradovate
TYPES: futures

FUNDEDFIRM DETAILS

STEPS: 1-phase
DRAWDOWN: Fixed
MARKETS: Forex
PLATFORMS: MT5

Bulenox PROS

+Single-step funding process is faster than the industry average of 1.6 steps.
+Profit target of 6% is below the industry average of 7.9%, making the evaluation easier to pass.
+Supports multiple platforms including NinjaTrader, Rithmic, and Tradovate.
+News trading and EA/automated trading are both permitted.

Bulenox CONS

−Max funding of $150,000 is significantly below the industry average of $839,272.7.
−Days to first payout of 14 is more than double the industry average of 6.5 days.
−Profit split of 80% is below the industry average of 84.7%.

FundedFirm PROS

+100% profit split is exceptionally above the industry average of 84.7%
+Days to first payout of 1 is significantly faster than the industry average of 6.5 days
+Single-step evaluation is below the industry average of 1.6 steps to funded
+Fee refund is available, reducing the net cost of the evaluation

FundedFirm CONS

−Max funding of $100,000 is well below the industry average of $839,272.70
−Min challenge cost of $549 is significantly above the industry average of $186.7
−Profit target of 10% is above the industry average of 7.9%, making evaluation harder to pass

PROPDNA VERDICT

Bulenox

Higher trust score (71/100). Slower payouts at 14d. 80% profit split.

START WITH BLNX